Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
245.6 EUR | -0.14% | -.--% | -.--% |
Apr. 26 | Roche: positive CHMP opinion for Alecensa | CF |
Apr. 26 | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ROG Stock
- RHO5 Stock
- Charts Roche Holding AG